Methods of using IGF1R and Abl kinase modulators

Details for Australian Patent Application No. 2007269540 (hide)

Owner Exelixis, Inc.

Inventors Zhang, Wentao

Agent Davies Collison Cave

Pub. Number AU-A-2007269540

PCT Pub. Number WO2008/005538

Priority 60/818,568 05.07.06 US

Filing date 3 July 2007

Wipo publication date 10 January 2008

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 January 2009 PCT application entered the National Phase

  PCT publication WO2008/005538 Priority application(s): WO2008/005538

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007269550-Flavors for oral compositions

2007269536-Method of treatment of hereditary hemochromatosis